Many recent studies also showed that the detection of GSTP1 promoter methylation in plasma, serum, or urine samples in combination with PSA screening significantly improved the diagnostic accuracy of PCa [37]. This evidence concerns the gene GSTP1 and posterior cortical atrophy.